Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Imject Alum is not aluminum hydroxide adjuvant or aluminum phosphate adjuvant.

× No keyword cloud information.

16 in total

1. Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs.

Authors: Gary R Matyas; Alexander V Mayorov; Kenner C Rice; Arthur E Jacobson; Kejun Cheng; Malliga R Iyer; Fuying Li; Zoltan Beck; Kim D Janda; Carl R Alving
Journal: Vaccine Date: 2013-04-23 Impact factor: 3.641

Review 2. Adjuvants for vaccines to drugs of abuse and addiction.

Authors: Carl R Alving; Gary R Matyas; Oscar Torres; Rashmi Jalah; Zoltan Beck
Journal: Vaccine Date: 2014-08-08 Impact factor: 3.641

3. Toward understanding the mechanism underlying the strong adjuvant activity of aluminum salt nanoparticles.

Authors: Tinashe B Ruwona; Haiyue Xu; Xu Li; Amber N Taylor; Yan-Chun Shi; Zhengrong Cui
Journal: Vaccine Date: 2016-05-05 Impact factor: 3.641

4. Evaluating the efficacy of rBmHATαc as a multivalent vaccine against lymphatic filariasis in experimental animals and optimizing the adjuvant formulation.

Authors: Gajalakshmi Dakshinamoorthy; Ramaswamy Kalyanasundaram
Journal: Vaccine Date: 2013-11-06 Impact factor: 3.641

5. Disparate adjuvant properties among three formulations of "alum".

Authors: Derek W Cain; Sergio E Sanders; Michael M Cunningham; Garnett Kelsoe
Journal: Vaccine Date: 2012-11-29 Impact factor: 3.641

6. T-helper 1 and T-helper 2 adjuvants induce distinct differences in the magnitude, quality and kinetics of the early inflammatory response at the site of injection.

Authors: Karen Smith Korsholm; Rune V Petersen; Else Marie Agger; Peter Andersen
Journal: Immunology Date: 2009-07-14 Impact factor: 7.397

7. Considerable differences in vaccine immunogenicities and efficacies related to the diluent used for aluminum hydroxide adjuvant.

Authors: Lin Lin; Ashraf S Ibrahim; Valentina Avanesian; John E Edwards; Yue Fu; Beverlie Baquir; Rebecca Taub; Brad Spellberg
Journal: Clin Vaccine Immunol Date: 2008-01-09

8. Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology.

Authors: Terianne M Wong; Nikolai Petrovsky; Stephanie J Bissel; Clayton A Wiley; Ted M Ross
Journal: Hum Vaccin Immunother Date: 2016-05-24 Impact factor: 3.452

9. The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm.

Authors: Tirth Raj Ghimire
Journal: Springerplus Date: 2015-04-16

10. Mechanism of immunopotentiation and safety of aluminum adjuvants.

Authors: Harm Hogenesch
Journal: Front Immunol Date: 2013-01-10 Impact factor: 7.561